NEUROPEPTIDE SF (HUMAN) manufacturers
|
| | NEUROPEPTIDE SF (HUMAN) Basic information |
| | NEUROPEPTIDE SF (HUMAN) Chemical Properties |
| density | 1.43±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | form | solid | | pka | 12.03±0.10(Predicted) | | color | White to off-white | | Water Solubility | Soluble to 1 mg/ml in 10% acetonitrile / sterile water | | Sequence | Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
| | NEUROPEPTIDE SF (HUMAN) Usage And Synthesis |
| Uses | Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH[1]. | | References | [1] Jászberényi M, et al., The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats. Regul Pept. 2014 Jan 10;188:46-51. DOI:10.1016/j.regpep.2013.11.004 |
| | NEUROPEPTIDE SF (HUMAN) Preparation Products And Raw materials |
|